These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28046082)

  • 1. The Phage Lysin PlySs2 Decolonizes Streptococcus suis from Murine Intranasal Mucosa.
    Gilmer DB; Schmitz JE; Thandar M; Euler CW; Fischetti VA
    PLoS One; 2017; 12(1):e0169180. PubMed ID: 28046082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus.
    Gilmer DB; Schmitz JE; Euler CW; Fischetti VA
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2743-50. PubMed ID: 23571534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Streptococcus suis prophage lysin as a new strategy for combating streptococci-induced mastitis and Streptococcus suis infection.
    Li XX; Zhang FQ; Wang S; Duan XC; Hu DY; Gao DY; Tao P; Li XM; Qian P
    J Antimicrob Chemother; 2023 Mar; 78(3):747-756. PubMed ID: 36659862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Csl2, a novel chimeric bacteriophage lysin to fight infections caused by Streptococcus suis, an emerging zoonotic pathogen.
    Vázquez R; Domenech M; Iglesias-Bexiga M; Menéndez M; García P
    Sci Rep; 2017 Nov; 7(1):16506. PubMed ID: 29184097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel prophage lysin Ply5218 with extended lytic activity and stability against Streptococcus suis infection.
    Zhang H; Zhang C; Wang H; Yan YX; Sun J
    FEMS Microbiol Lett; 2016 Sep; 363(18):. PubMed ID: 27481700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purified recombinant phage lysin LySMP: an extensive spectrum of lytic activity for swine streptococci.
    Wang Y; Sun JH; Lu CP
    Curr Microbiol; 2009 Jun; 58(6):609-15. PubMed ID: 19267155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial activity of nisin against the swine pathogen Streptococcus suis and its synergistic interaction with antibiotics.
    Lebel G; Piché F; Frenette M; Gottschalk M; Grenier D
    Peptides; 2013 Dec; 50():19-23. PubMed ID: 24096107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an inducible bacteriophage in a virulent strain of Streptococcus suis serotype 2.
    Harel J; Martinez G; Nassar A; Dezfulian H; Labrie SJ; Brousseau R; Moineau S; Gottschalk M
    Infect Immun; 2003 Oct; 71(10):6104-8. PubMed ID: 14500539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal immunization with a live Streptococcus suis isogenic ofs mutant elicited suilysin-neutralization titers but failed to induce opsonizing antibodies and protection.
    Kock C; Beineke A; Seitz M; Ganter M; Waldmann KH; Valentin-Weigand P; Baums CG
    Vet Immunol Immunopathol; 2009 Dec; 132(2-4):135-45. PubMed ID: 19505730
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Xi H; Fu Y; Chen C; Feng X; Han W; Gu J; Ji Y
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068990
    [No Abstract]   [Full Text] [Related]  

  • 11. Amentoflavone Ameliorates Streptococcus suis-Induced Infection
    Shen X; Niu X; Li G; Deng X; Wang J
    Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30315078
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetic-pharmacodynamic modeling of tylosin against Streptococcus suis in pigs.
    Huang L; Zhang H; Li M; Ahmad I; Wang Y; Yuan Z
    BMC Vet Res; 2018 Oct; 14(1):319. PubMed ID: 30355326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophage lysin Ply30 protects mice from Streptococcus suis and Streptococcus equi subsp. zooepidemicus infections.
    Tang F; Li D; Wang H; Ma Z; Lu C; Dai J
    Appl Environ Microbiol; 2015 Nov; 81(21):7377-84. PubMed ID: 26253669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the Phage Lysin Ply5218 in the Treatment of
    Wang Z; Ma J; Wang J; Yang D; Kong L; Fu Q; Cheng Y; Wang H; Yan Y; Sun J
    Viruses; 2019 Aug; 11(8):. PubMed ID: 31387285
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimicrobial susceptibility of Streptococcus suis isolated from diseased pigs, asymptomatic pigs, and human patients in Thailand.
    Yongkiettrakul S; Maneerat K; Arechanajan B; Malila Y; Srimanote P; Gottschalk M; Visessanguan W
    BMC Vet Res; 2019 Jan; 15(1):5. PubMed ID: 30606175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of Streptococcus suis isolated from swine in France and from humans in different countries between 1996 and 2000.
    Marie J; Morvan H; Berthelot-Hérault F; Sanders P; Kempf I; Gautier-Bouchardon AV; Jouy E; Kobisch M
    J Antimicrob Chemother; 2002 Aug; 50(2):201-9. PubMed ID: 12161400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel endolysin disrupts Streptococcus suis with high efficiency.
    Ji W; Huang Q; Sun L; Wang H; Yan Y; Sun J
    FEMS Microbiol Lett; 2015 Dec; 362(24):fnv205. PubMed ID: 26534896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Galleria mellonella larvae for studying the virulence of Streptococcus suis.
    Velikova N; Kavanagh K; Wells JM
    BMC Microbiol; 2016 Dec; 16(1):291. PubMed ID: 27978817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance and prudent drug use for Streptococcus suis.
    Varela NP; Gadbois P; Thibault C; Gottschalk M; Dick P; Wilson J
    Anim Health Res Rev; 2013 Jun; 14(1):68-77. PubMed ID: 23683342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Streptococcus suis isolates from the diseased pigs in China between 2003 and 2007.
    Wei Z; Li R; Zhang A; He H; Hua Y; Xia J; Cai X; Chen H; Jin M
    Vet Microbiol; 2009 May; 137(1-2):196-201. PubMed ID: 19185432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.